Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 151 to 160 of 1514 total matches.

Zinc for the Common Cold

   
The Medical Letter on Drugs and Therapeutics • Jan 31, 1997  (Issue 993)
, Vol. 39 (Issue 993) January 31, 1997, pp. 9-10 Copyright  The Medical Letter UNAUTHORIZED ...
Results of a recent study suggested that zinc gluconate may be effective in treating the common cold (SB Mossad et al, Ann Intern Med, 125:81, July 15, 1996). Zinc gluconate lozenges, sometimes combined with vitamin C or other ingredients, are available in pharmacies and health food stores throughout the USA.
Med Lett Drugs Ther. 1997 Jan 31;39(993):9-10 |  Show IntroductionHide Introduction

Glatiramer Acetate for Relapsing Multiple Sclerosis

   
The Medical Letter on Drugs and Therapeutics • Jul 04, 1997  (Issue 1004)
effectiveness. The Medical Letter, Vol. 39 (Issue 1004) July 4, 1997, pp. 61-62 Copyright  The Medical Letter ...
Glatiramer acetate (Copaxone - Teva Marion Partners), formerly known as copolymer-l, has been approved by the US Food and Drug Administration (FDA) for treatment of relapsing-remitting multiple sclerosis (MS). Interferon β-1b (Betaseron) and interferon β-1a (Avonex - Medical Letter, 38:63, 1996) were previously approved for this indication.
Med Lett Drugs Ther. 1997 Jul 4;39(1004):61-2 |  Show IntroductionHide Introduction

Glucosamine for Osteoarthritis

   
The Medical Letter on Drugs and Therapeutics • Sep 26, 1997  (Issue 1010)
that has been reported to maintain The Medical Letter, Vol. 39 (Issue 1010) September 26, 1997, pp. 91-92 Copyright ...
The Medical Letter has received many inquiries about use of glucosamine, a basic constituent of articular cartilage glycosaminoglycans, for treatment of arthritis. A recently published book (The Arthritis Cure), several television news shows, and articles in The New York Times have suggested it may be effective for treatment of osteoarthritis. Glucosamine is sold as a 'dietary supplement' in the USA.
Med Lett Drugs Ther. 1997 Sep 26;39(1010):91-2 |  Show IntroductionHide Introduction

Tamsulosin for Benign Prostatic Hyperplasia

   
The Medical Letter on Drugs and Therapeutics • Oct 10, 1997  (Issue 1011)
. The Medical Letter, Vol. 39 (Issue 1011) October 10, 1997, p. 96 Copyright  The Medical Letter UNAUTHORIZED ...
Tamsulosin (Flomax - Boehringer Ingelheim), an alpha 1 - adrenoreceptor blocker, has been approved by the FDA for treatment of benign prostatic hyperplasia (BPH). It is claimed to bind preferentially to alpha1 receptors in the prostate.
Med Lett Drugs Ther. 1997 Oct 10;39(1011):96 |  Show IntroductionHide Introduction

Olopatadine for Allergic Conjunctivitis

   
The Medical Letter on Drugs and Therapeutics • Nov 21, 1997  (Issue 1014)
allergy-like symptoms are limited in effectiveness and may be irritating The Medical Letter, Vol. 39 ...
Olopatadine hydrochloride (Patanol - Alcon), a propilidinedibenzoxypin derivative, has recently been marketed in a 0.1% ophthalmic solution for prevention of itching due to allergic conjunctivitis in adults and children more than three years old. It is the first drug for this indication that both inhibits mast cell degranulation and is a selective histamine H1 receptor antagonist (NA Sharif et al, J Pharmacol Exp Ther, 278:1252, 1996).
Med Lett Drugs Ther. 1997 Nov 21;39(1014):108-9 |  Show IntroductionHide Introduction

Arbutamine for Stress Testing

   
The Medical Letter on Drugs and Therapeutics • Jan 30, 1998  (Issue 1019)
(AR Shehata et al, Am J Cardiol, 80:716, 1997). The Medical Letter, Vol. 40 (Issue 1019) January 30 ...
Myocardial perfusion imaging and stress echocardiography in patients who cannot exercise may require use of drugs. Arbutamine (GenESA - Gensia Automedics), a potent synthetic sympathomimetic, has recently been approved by the FDA for use with a computerized drug-delivery system in pharmacologic stress testing.
Med Lett Drugs Ther. 1998 Jan 30;40(1019):19-20 |  Show IntroductionHide Introduction

Raloxifene for Postmenopausal Osteoporosis

   
The Medical Letter on Drugs and Therapeutics • Mar 13, 1998  (Issue 1022)
to wholesale price (AWP) listings in First DataBank PriceAlert, February 15, 1998. The Medical Letter, Vol. 40 ...
Raloxifene (Evista - Lilly), a benzothiophene that acts on estrogen receptors, has recently been marketed for prevention of postmenopausal osteoporosis. Only estrogen (alone or in combination with a progestin) and the bisphosphonate alendronate (Fosamax) were previously approved by the FDA for this indication.
Med Lett Drugs Ther. 1998 Mar 13;40(1022):29-30 |  Show IntroductionHide Introduction

Sibutramine for Obesity

   
The Medical Letter on Drugs and Therapeutics • Mar 13, 1998  (Issue 1022)
daily, blood pressure and heart rate permitting. The drug is available in 5-, The Medical Letter, Vol ...
Sibutramine hydrochlorid monohydreate (Meridia - Knoll), which is structurally related to amphetamine, has been approved by the FDA for treatment of obesity. It is classified by the Drug Enforcement Agency (DEA) as a schedule IV controlled substance.
Med Lett Drugs Ther. 1998 Mar 13;40(1022):32 |  Show IntroductionHide Introduction

Dolasetron for Prevention of Nausea and Vomiting Due to Cancer Chemotherapy

   
The Medical Letter on Drugs and Therapeutics • May 08, 1998  (Issue 1026)
and carcinomas in mice. The Medical Letter, Vol. 40 (Issue 1026) May 8, 1998, pp. 53-54 Copyright  The Medical ...
Dolasetron (Anzemet - Hoechst Marion Roussel), a selective serotonin (5-HT3) receptor antagonist similar to ondansetron (Zofran) and granisetron (Kytril - Medical Letter, 36:61, 1994) is now available for both oral and intravenous use in prevention of nausea and vomiting due to cancer chemotherapy. A 5-HT3 antagonist plus dexamethasone (Decadron, and others) is the most effective regimen for prevention of acute vomiting caused by cancer chemotherapy. Dolasetron has also been approved by the FDA for prevention and treatment of postoperative nausea and...
Med Lett Drugs Ther. 1998 May 8;40(1026):53-4 |  Show IntroductionHide Introduction

Ginkgo Biloba for Dementia

   
The Medical Letter on Drugs and Therapeutics • Jun 19, 1998  (Issue 1029)
including 10,815 patients with dementia, only 183 The Medical Letter, Vol. 40 (Issue 1029) June 19, 1998 ...
Extracts made from leaves of the ginkgo tree (Ginkgo biloba) are available in the uSA as deitary supplements, in France and Germany as licensed drugs and worldwide as herbal remedies for treatment of dementia and many other indications.
Med Lett Drugs Ther. 1998 Jun 19;40(1029):63-4 |  Show IntroductionHide Introduction